Lung parasitic diseases von Larbaoui, D.

Volltext

Prevention of tuberculosis in health-care personnel von Larbaoui, D.

Volltext

218-PA12 Evolution des habitudes tabagiques de la population de la wilaya d'Alger de 1984 à 1994 von Skander, F., Bellamdani, M., Larbaoui, D.

Volltext

Intermittent chemotherapy with isoniazid and streptomycin in Algiers von Chaulet, P., Larbaoui, D., Grosset, J., Abdfrrahim, K.

Volltext

Some economic aspects of tuberculosis control in Algeria von Mokhtari, L., Benghezal, A., Chaulet, P., Larbaoui, D.

Volltext

The treatment of INH-RMP tuberculosis resistant cases von Larbaoui, D., Khaled, S., Boulahbal, F.

Volltext

What role can the Algerian Red Crescent play in the anti-tuberculosis campaign? von Larbaoui, D.

Volltext

Quel rôle le Croissant-Rouge algérien peut-il jouer dans la lutte antituberculeuse? von Larbaoui, D.

Volltext

The efficiency of methods of diagnosing pulmonary tuberculosis: An investigation in a chest clinic in algiers von Larbaoui, D., Chaulet, P., Grosset, T., Abderrahim, K., Ait-Mesbah, H.

Volltext

Etude de la résistance primaire de Mycobacterium tuberculosis aux antibiotiques en Algérie, de 1973 à 1977 von Gibelin, P., Gibelin, M., Lamrani, Z., Larbaoui, D.

Volltext

Enquête épidémiologique sur le kyste hydatique en Algérie en 1977 von Gibelin, P., Gibelin, M., Alloula, R., Larbaoui, D.

Volltext

Clinical experience in Algeria of intermittent treatment of pulmonary tuberculosis with isoniazid and streptomycin twice-weekly von Chaulet, P., Abderrahim, K., Grosset, J., Larbaout, D.

Volltext

Sensitivity to thiacetazone of strains of mycobacterium tuberculosis isolated in Algiers: Practical deductions von Grosset, J., Rodrigues, F., Benhassine, M., Chaulet, P., Larbaoud, D.

Volltext

RM-042Biliary tract cancer: a retrospective study von Zemmour, A, Larbaoui, B, Yekrou, D, Boudinar Fatima, Z, Rekai, K

Volltext

RM-003Neoadjuvant chemotherapy on advanced gastric carcinoma von Zemmour, A, Larbaoui, B, Yekrou, D, Boudinar Fatima, Z, Rekai, K

Volltext

RM-023Epidemiology and clinical aspects of the canal anal cancer von Zemmour, A, Larbaoui, B, Yekrou, D, Boudinar Fatima, Z, Rekai, K

Volltext

Everolimus as first-line or after cytokine therapy in patients with metastatic recurrent and/or unresectable renal cell carcinoma (RCC) (EVERMORE) von Abdel Hakim, A.M., Nouira, Y., Taran, R., Amokrane, D., Ghosn, M., Larbaoui, B., Pripatnanont, C., Slimane, K., Pilipovic, V., Boussen, H.

Volltext

Biomarker testing practices in the SECURE (proSpective obsErvational clinical practiCe stUdy in the first-line management of metastatic colorectal cancer [mCRC] with eRbitux in com... von Aravantinos, G., Shahrasbi, A., Oukkal, M., Larbaoui, B., Ronga, P., Messinger, D., Hamad, J., Benbrahim, W.

Volltext

890PEverolimus as first-line or after cytokine therapy in patients with metastatic recurrent and/or unresectable renal cell carcinoma (RCC) (EVERMORE) von Abdel Hakim, A M, Nouira, Y, Taran, R, Amokrane, D, Ghosn, M, Larbaoui, B, Pripatnanont, C, Slimane, K, Pilipovic, V, Boussen, H

Volltext

RM-042 Biliary tract cancer: a retrospective study von Zemmour, A., Larbaoui, B., Yekrou, D., Boudinar Fatima, Z., Rekai, K.

Volltext